ASHP
The MCPHS Biopharmaceutical Industry Fellowship Program and its sponsors are pleased to offer the following Post PharmD Fellowship positions. All positions can be found throughout the PPS site as well.
MCPHS/Agios
Clinical Development, Clinical Scientist Clinical Supply Chain (Not Recruiting) Clinical GMP – Quality Assurance (Not Recruiting) Health Economics & Outcomes Research (HEOR) (Not Recruiting) Medical Safety Risk Management Medical Affairs Regulatory Affairs (Not Recruiting) MCPHS/Alexion
Global Medical Communications / Global Medical Affairs Global Patient Safety Global Regulatory Affairs Global Value, Access, & Pricing Product Development & Clinical Supply US Market Access
*NEW* US Medical Affairs US Review and Strategy MCPHS/Biogen
Regulatory Affairs: Regulatory Strategy Global Medical Writing Therapeutics Development US Marketing US Medical Worldwide Medical MCPHS/Moderna
Clinical Operations Clinical Safety & Pharmacovigilance Global Regulatory Sciences (Not Recruiting) MCPHS/Novartis
Biomarker Development (BMD) Research & Development Quality Assurance Early Clinical Development – Translational Medicine Early Clinical Development- Translational Clinical Oncology (TCO) Regulatory Affairs (RA) MCPHS/Pfizer
Global Clinical Supply (Clinical Research Pharmacy) MCPHS/Sanofi
Clinical Documentation & Medical Writing – Specialty Care Portfolio (Not Recruiting) Global Regulatory Affairs – Specialty Care Portfolio Global Regulatory Affairs: Chemistry, Manufacturing, Controls & Devices – Specialty Care Portfolio Global/Scientific Medical Communications – Immunology Global/Scientific Medical Communications – Neurology Global/Scientific Medical Communications – Oncology (Not Recruiting) Global/Scientific Medical Communications – Rare Diseases Global/Scientific Medical Communications (Pipeline) – Immunology Global/US Commercial Strategy – Oncology Global/US Commercial Strategy and Marketing – Rare Diseases Global/US Medical/MSL – Oncology Medical Innovation & Strategic Planning – Specialty Care Portfolio Patient Safety & Pharmacovigilance – Specialty Care Portfolio US Medical Value & Outcomes – Specialty Care Portfolio US Medical/MSL – Rare Blood Disorders US Medical/MSL- Rare Diseases US Medical/MSL – Immunology US Medical/MSL – Neurology US Public Affairs & Patient Advocacy – Specialty Care Portfolio MCPHS/Sarepta Therapeutics
Global Medical Affairs (Not Recruiting) MCPHS/Schrödinger
Clinical Development (Not Recruiting) MCPHS/Takeda
Global Clinical Supply Chain Global Medical Information & Review (Oncology) (1 year) Global Scientific Communications, Oncology (Not Recruiting) Global Patient Safety & Pharmacovigilance MCPHS/Travere
Medical Information/Medical Affairs Visit our website for full details, company brochures and the application portal. The MCPHS Biopharmaceutical Industry Fellows will be selected on a nationally competitive basis. Eligibility
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program. Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry. All candidates must have authorization to work in the United States throughout the duration of the one- or two-year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.). Application Procedure
The MCPHS application portal (SMApply) will open up on Monday, October 6, 2025. Applicants must upload the following application materials to the online portal by Monday, November 3, 2025: Letter of intent (addressed to the company specific program director/lead; found in each company brochure) Curriculum vitae Unofficial college transcript Contact information for three references. References will receive an electronic recommendation form to complete separately. Three recommendation evaluation forms must be submitted no later than November 20, 2025 via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply. Application Review and Interview Timeline
Following a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore, candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early. ASHP Midyear and Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Las Vegas, NV. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details. Top candidates may be invited for interviews at the sponsoring company’s location. AIFA First Offer Date
The choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than Friday, December 12, 2025. We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date. We see this respect for candidate choice as a common aspect of each of our Program\'s cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline. Learn more about AIFA affiliated programs. Onboarding
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
#J-18808-Ljbffr
Clinical Development, Clinical Scientist Clinical Supply Chain (Not Recruiting) Clinical GMP – Quality Assurance (Not Recruiting) Health Economics & Outcomes Research (HEOR) (Not Recruiting) Medical Safety Risk Management Medical Affairs Regulatory Affairs (Not Recruiting) MCPHS/Alexion
Global Medical Communications / Global Medical Affairs Global Patient Safety Global Regulatory Affairs Global Value, Access, & Pricing Product Development & Clinical Supply US Market Access
*NEW* US Medical Affairs US Review and Strategy MCPHS/Biogen
Regulatory Affairs: Regulatory Strategy Global Medical Writing Therapeutics Development US Marketing US Medical Worldwide Medical MCPHS/Moderna
Clinical Operations Clinical Safety & Pharmacovigilance Global Regulatory Sciences (Not Recruiting) MCPHS/Novartis
Biomarker Development (BMD) Research & Development Quality Assurance Early Clinical Development – Translational Medicine Early Clinical Development- Translational Clinical Oncology (TCO) Regulatory Affairs (RA) MCPHS/Pfizer
Global Clinical Supply (Clinical Research Pharmacy) MCPHS/Sanofi
Clinical Documentation & Medical Writing – Specialty Care Portfolio (Not Recruiting) Global Regulatory Affairs – Specialty Care Portfolio Global Regulatory Affairs: Chemistry, Manufacturing, Controls & Devices – Specialty Care Portfolio Global/Scientific Medical Communications – Immunology Global/Scientific Medical Communications – Neurology Global/Scientific Medical Communications – Oncology (Not Recruiting) Global/Scientific Medical Communications – Rare Diseases Global/Scientific Medical Communications (Pipeline) – Immunology Global/US Commercial Strategy – Oncology Global/US Commercial Strategy and Marketing – Rare Diseases Global/US Medical/MSL – Oncology Medical Innovation & Strategic Planning – Specialty Care Portfolio Patient Safety & Pharmacovigilance – Specialty Care Portfolio US Medical Value & Outcomes – Specialty Care Portfolio US Medical/MSL – Rare Blood Disorders US Medical/MSL- Rare Diseases US Medical/MSL – Immunology US Medical/MSL – Neurology US Public Affairs & Patient Advocacy – Specialty Care Portfolio MCPHS/Sarepta Therapeutics
Global Medical Affairs (Not Recruiting) MCPHS/Schrödinger
Clinical Development (Not Recruiting) MCPHS/Takeda
Global Clinical Supply Chain Global Medical Information & Review (Oncology) (1 year) Global Scientific Communications, Oncology (Not Recruiting) Global Patient Safety & Pharmacovigilance MCPHS/Travere
Medical Information/Medical Affairs Visit our website for full details, company brochures and the application portal. The MCPHS Biopharmaceutical Industry Fellows will be selected on a nationally competitive basis. Eligibility
Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program. Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry. All candidates must have authorization to work in the United States throughout the duration of the one- or two-year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.). Application Procedure
The MCPHS application portal (SMApply) will open up on Monday, October 6, 2025. Applicants must upload the following application materials to the online portal by Monday, November 3, 2025: Letter of intent (addressed to the company specific program director/lead; found in each company brochure) Curriculum vitae Unofficial college transcript Contact information for three references. References will receive an electronic recommendation form to complete separately. Three recommendation evaluation forms must be submitted no later than November 20, 2025 via the online portal. This is NOT a letter of recommendation but an online form that the recommender will receive for completion from SMApply. Application Review and Interview Timeline
Following a review of submitted applications, pre-screens and preliminary interviews will begin in October. Additional interviews, including final rounds will take place in December during ASHP. Candidates will be notified if selected for an interview. The process is rigorous and competitive; therefore, candidates should submit their applications well in advance of posted deadlines as priority will be given to those who apply early. ASHP Midyear and Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Las Vegas, NV. Attendance is strongly encouraged, but not required. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details. Top candidates may be invited for interviews at the sponsoring company’s location. AIFA First Offer Date
The choice of a Post-Doctoral Fellowship is an important decision. MCPHS, in conjunction with the Alliance of Industry Fellowship Associates (AIFA), has aligned to extend offers for Fellowships no earlier than Friday, December 12, 2025. We believe this is a positive reflection of the cultures our Programs offer, and that culture is a critical consideration in choice of Fellowship. We hope that other academic and non-academic Fellowship Programs will NOT pressure candidates to accept offers prior to this aligned offer date. We see this respect for candidate choice as a common aspect of each of our Program\'s cultures. We hope that other academic and non-academic Fellowship Programs will respect this timeline. Learn more about AIFA affiliated programs. Onboarding
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
#J-18808-Ljbffr